Comparison |
| Alternate Manufacturer Number |
1558626 | | 2662757 | 2054724 | |
| Container Type |
Single-Dose Applicator | Prefilled Syringe | Prefilled Syringe | Pouch | Prefilled Syringe |
| Dosage Form |
Gel | Injection | Injection | Patch | Injection |
| Generic Drug Code |
48142 | 11254 | 11254 | 15524 | 24471 |
| Generic Drug Name |
Lactic Acid / Citric Acid / Potassium Bitartrate | Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | Norelgestromin / Ethinyl Estradiol | Medroxyprogesterone Acetate |
| NDC Number |
69751010012 | 00009737611 | 55150033001 | 00378334053 | 00009470913 |
| Quantity |
12 Applicators | | | 3 Patches | |
| Strength |
5 Gram | 150 mg / mL | 150 mg / mL | 150 mcg - 35 mcg / 24 Hour | 104 mg / 0.65 mL |
| Type |
Vaginal | Intramuscular | Intramuscular | Transdermal | Subcutaneous |
| UNSPSC Code |
51352400 | 51351612 | 51351509 | 51352414 | 51351612 |
| Volume |
| 1 mL | 1 mL | | 0.65 mL |
| Application |
Contraceptive Agent | Contraceptive Agent | Contraceptive Agent | Contraceptive Agent | Contraceptive Agent |
| Country of Origin |
Unknown | Unknown | Unknown | Unknown | Unknown |
| Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
| Features and Benefits |
- PHEXXI™ is indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception
- PHEXXI™ (lactic acid, citric acid, and potassium bitartrate) vaginal gel is an off-white to tan color gel of uniform consistency containing lactic acid (1.8%), citric acid (1%), and potassium bitartrate (0.4%), supplied as individually wrapped 5 gram pre-filled single-dose vaginal applicators in sealed foil pouches along with a plunger
|
- Depo-Provera CI is a progestin indicated only for the prevention of pregnancy
- The recommended dose is 150 mg of Depo-Provera CI every 3 months (13 weeks) administered by deep, intramuscular (IM) injection in the gluteal or deltoid muscle
- Prefilled syringes packaged with 22-gauge x 1-1/2 inch Terumo® SurGuard™ needles
- Store at controlled room temperature 20° to 25°C (68° to 77°F) [see USP]
|
|
|
- depo-subQ provera 104 must be given by subcutaneous injection into the anterior thigh or abdomen, once every 3 months (12 to 14 weeks)
- depo-subQ provera 104 is not formulated for intramuscular injection
- The pre-filled syringe of depo-subQ provera 104 must be vigorously shaken just before use to create a uniform suspension
- Supplied as a pre-filled syringe, packaged with a 26-gauge x 3/8 inch Terumo® Surguard™ needle
- Store at controlled room temperature 20º to 25º C (68º to 77ºF)
|
